Revenue: The sum of all revenue fields included for a company's operating activities.
Gossamer Bio, Inc. (GOSS) had Revenue of $13.80M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$13.80M |
$-47.24M |
|
-- |
|
$13.80M |
|
$59.84M |
|
$-46.04M |
|
$-1.29M |
|
$-47.33M |
|
$-47.33M |
|
$-47.24M |
|
$-47.24M |
|
$-47.24M |
|
$-47.24M |
|
$-46.04M |
|
$-46.64M |
|
228.52M |
|
228.52M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$167.64M |
|
$0.06M |
|
$4.61M |
|
$172.25M |
|
$63.44M |
|
$198.51M |
|
$231.57M |
|
$295.01M |
|
$-122.76M |
|
$-122.76M |
|
$-122.76M |
|
233.68M |
|
| Cash Flow Statement Financials | |
$-171.27M |
|
$156.36M |
|
$6.42M |
|
$46.07M |
|
$37.73M |
|
$-8.34M |
|
$10.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.64 |
|
-- |
|
-- |
|
2.62 |
|
-1.62 |
|
100.00% |
|
-333.64% |
|
-333.64% |
|
-- |
|
-342.97% |
|
-342.33% |
|
$-171.34M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
1.13 |
|
79.75 |
|
38.48% |
|
38.48% |
|
-27.42% |
|
-62.36% |
|
$-0.53 |
|
$-0.75 |
|
$-0.75 |
|